Pillstats
Rx only · Capsule · Oral

Triamterene

Brands: Dyrenium · Triamterene

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC03DB02
RxCUI (US)10763
US makers3 labelers
Packages8
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.09$4.19$6.28$8.38Dec 2025Apr 2026Jul 2026
$6.578
Latest avg · Jul 22, 2026
-9%
Since Dec 17, 2025
3
Active US suppliers
75%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

771542303072025 Q12025 Q22025 Q32025 Q42026 Q1
246
Rx · 2026 Q1
15K
Units dispensed
+137%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Biocon Pharma Incunknown4SUPPLYING
Advanz Pharma (US) Corp.unknown2SUPPLYING
Prasco Laboratoriesunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.